Biologic “Functional Equivalence” Being Considered By Insurers – WellPoint
Managed care plans increasingly are moving toward selecting preferred biologic agents within a therapeutic class, WellPoint VP & Chief Pharmacy Officer Robert Seidman said
Managed care plans increasingly are moving toward selecting preferred biologic agents within a therapeutic class, WellPoint VP & Chief Pharmacy Officer Robert Seidman said